PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Pgc-1α was also downregulated in obesity and NAFLD [87], and as a consequence, we observed decreasing β-oxidation, oxidative phosphorylation, mitochondrial biogenesis, and insulin resistance [85,87].